2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Gastrointestinal
4
Genitourinary
2
Breast
1
Conditions
Motor Activity
20
Polycystic Ovary Syndrome
10
Prostatic Neoplasms
7
Breast Neoplasms
6
Neoplasms
5
Colorectal Neoplasms
4
Insulin Resistance
3
Lung Neoplasms
2
Fatigue
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lupus Erythematosus, Systemic
1
Inflammation
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Disease
1
Diabetes Mellitus, Type 1
1
Chemotherapy-Related Cognitive Impairment
1
Cardiovascular Diseases
1
Interventions
Fluorouracil
497
Bevacizumab
476
Oxaliplatin
449
Leucovorin
440
Irinotecan
408
Cetuximab
317
Capecitabine
317
pembrolizumab
142
Folfox protocol
129
Panitumumab
117
regorafenib
105
Colonoscopy
88
Nivolumab
81
IFL protocol
81
Drug Therapy
77
trifluridine tipiracil drug combination
73
Radiotherapy
66
HMPL-013
65
Blood Specimen Collection
52
Gemcitabine
49
Specimen Handling
46
Neoadjuvant Therapy
45
Standard of Care
44
Magnetic Resonance Spectroscopy
43
Biopsy
43
Chemotherapy, Adjuvant
41
Trifluridine
40
atezolizumab
38
Surveys and Questionnaires
38
Cyclophosphamide
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
High-Intensity Interval Training
×
Clear all
NCT04558398
2026-04-29
ICCE-Mito
University of Nottingham
Phase NA
Completed
15 enrolled
NCT04923672
2024-10-16
ExPre 01
University of Virginia
Phase NA
Terminated
10 enrolled
NCT02473003
2023-12-21
Phys-Can
Uppsala University
Phase NA
Unknown
600 enrolled
NCT04715061
2022-11-07
CANEX-2
Université de Sherbrooke
Phase NA
Completed
19 enrolled